UBS Group’s Xylem XYL Stock Holding History

UBS Group’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.22M	Sell	18,564 -1,400	-7%	-$184K	﹤0.01%	4879
2025 Q4	$2.72M	Sell	19,964 -25,682	-56%	-$3.69M	﹤0.01%	4672
2025 Q3	$6.73M	Hold	45,646	–	–	﹤0.01%	3726
2025 Q2	$5.9M	Sell	45,646 -3,600	-7%	-$436K	﹤0.01%	3707
2025 Q1	$5.88M	Buy	49,246 +3,600	+8%	+$446K	﹤0.01%	3616
2024 Q4	$5.3M	Hold	45,646	–	–	﹤0.01%	3787
2024 Q3	$6.16M	Hold	45,646	–	–	﹤0.01%	2855
2024 Q2	$6.19M	Buy	45,646 +18,564	+69%	+$2.53M	﹤0.01%	2645
2024 Q1	$3.5M	Buy	+27,082	New	+$3.27M	﹤0.01%	3359
2015 Q2	–	Sell	-300	Closed	-$11K	–	8892
2015 Q1	$11K	Sell	300 -2,200	-88%	-$77.6K	﹤0.01%	7578
2014 Q4	$95K	Buy	+2,500	New	+$91.4K	﹤0.01%	5755

Other funds holding XYL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

UBS Group's XYL Position: Q1 2026 in Review

UBS Group reduced its Xylem (XYL) stake by 10% in Q1 2026, selling an estimated $16.1M and leaving 1,075,083 shares worth $128M. The position accounts for 0.02% of the portfolio, ranked #862.

UBS Group first reported a position in XYL in Q4 2014 and has held it in 46 quarters since. The position peaked at $235M in Q4 2024. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

UBS Group held 1,075,083 shares of Xylem worth $128M as of Q1 2026.
UBS Group sold 122,952 Xylem shares in Q1 2026, an estimated $16.1M.
Xylem made up 0.02% of UBS Group's portfolio in Q1 2026, its #862 holding.
UBS Group first reported a position in Xylem in Q4 2014 and has held it in 46 quarters since.
UBS Group's Xylem position peaked at $235M in Q4 2024.
1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.